Androgen Receptor (phospho Ser650) Cell Based ELISA Kit (A102707)

Androgen Receptor (phospho Ser650) Cell Based ELISA Kit

Cell-based (qualitative)

This Androgen Receptor (phospho Ser650) Cell Based ELISA Kit allows for the detection of Androgen Receptor (phospho Ser650) and the effects that certain stimulation conditions have on Androgen Receptor (phospho Ser650) expression in different cell lines. Qualitative determination of Androgen Receptor (phospho Ser650) concentration is achieved by an indirect ELISA format. In essence, the Androgen Receptor (phospho Ser650) is captured by Anti-Androgen Receptor (phospho Ser650) Antibodies which in turn are detected by HRP-conjugated secondary antibodies. Through this binding, the HRP enzyme (conjugated to the secondary antibody) can catalyze a colorimetric reaction upon substrate addition. Due to the qualitative nature of this Androgen Receptor (phospho Ser650) Cell Based ELISA Kit, multiple normalization methods are described: 1) Anti-GAPDH Antibody is included to serve as an internal positive control in normalizing the target absorbance values. 2) Following the colorimetric measurement of HRP activity via substrate addition, the Crystal Violet whole-cell staining method is used to determine cell density. After staining, the results can be analyzed by normalizing the absorbance values to cell amounts, by which the plating difference can be adjusted. 3) Anti-Androgen Receptor Antibody is provided for normalization purposes. The absorbance values obtained for the non-phosphorylated target can be used to normalize the absorbance values for the phosphorylated target.

Microplate

Adherent cells and suspension cells.

> 5000 Cells

4 hours 30 minutes

Human

Store at + 4°C. Stable for 6 months.

AIS, Androgen nuclear receptor variant 2, Androgen receptor (dihydrotestosterone receptor; testicular feminization; spinal and bulbar muscular atrophy; Kennedy disease), androgen receptor splice variant 4b, ANDR_HUMAN, AR, AR8, DHTR, Dihydro testosterone receptor, Dihydrotestosterone receptor, Dihydrotestosterone receptor (DHTR), HUMARA, HYSP1, KD, Kennedy disease (KD), NR3C4, Nuclear receptor subfamily 3 group C member 4, Nuclear receptor subfamily 3 group C member 4 (NR3C4), SBMA, SMAX1, Spinal and bulbar muscular atrophy, Spinal and bulbar muscular atrophy (SBMA), Testicular Feminization (TFM), TFM